Eisai Inc. announced today that BELVIQ (pronounced BEL-VEEK) will be available to eligible patients by prescription in the United States beginning June 11.
BELVIQ was approved by the U.S. Food and Drug Administration on June 27, 2012 to be used along with a reduced-calorie diet and increased physical activity for chronic weight management in adults who have a body mass index (BMI) of 30 kg/m² or greater (obese), or BMI of 27 kg/m² or greater (overweight) with at least one weight-related medical condition such as high blood pressure, high cholesterol, or type 2 diabetes. It is not known if BELVIQ is safe and effective when taken with other prescription, over-the-counter, or herbal weight loss products, nor is it known if BELVIQ changes your risk of heart problems or stroke, or of death due to heart problems or stroke.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/60316-eisai-belviq-civ-chronic-weight-management-tablets-for-overweight-adults
Summer is right around the corner and although we wear sunscreen to protect our skin we often forget about our eyes. Women of color are at higher risk for vision complications which can be linked to UV exposure. Transitions® lenses automatically change from clear indoors to dark outdoors, blocking harmful UV rays and reducing glare, and they can be fitted with your favorite designer frame styles.
Barclaycard US, the payments business of Barclays in the United States, today announced that it has partnered with FICO (NYSE: FICO), a leading predictive analytics and decision management software company, to offer complimentary FICO® Scores to its cardmembers. Barclaycard is the first top 10 issuer to provide FICO® Scores to its cardmembers, giving them unprecedented access to the same credit score used by banks and lenders at no additional cost.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/64068-barclaycard-offers-complimentary-fico-scores-to-cardmembers
A ten-month clinical trial at Sentara Leigh Hospital in Norfolk, Virginia has determined that hard surfaces and linens infused with copper oxide compounds contributed to an 83% reduction in C-difficile and a 78% overall reduction in a host of multi-drug resistant organisms (MDROs) including C-diff, MRSA and VRE in a real-world clinical environment. These results occurred in a hospital with a robust protocol for managing infection risk certified by the health care accrediting body DNV-GL Healthcare.
The results of the trial were published in the peer-reviewed American Journal of Infection Control on Sept. 28, 2016 and will be presented at the annual conference of the Infectious Disease Society of America in New Orleans, Louisiana on October 27, 2016.
To view the multimedia release go to:
http://www.multivu.com/players/English/7955751-sentara-healthcare-infections-copper-clinical-trial/
Jerome Bettis and Robin Miller are teaming up with Sanofi US to raise awareness of life-threatening allergic reactions (anaphylaxis) and spread the word that Auvi-Q™ (epinephrine injection, USP) is now available by prescription in pharmacies nationwide. Bettis, who is allergic to shellfish, and Miller, who is allergic to eggs, hope to help educate adults and caregivers of children at risk for severe allergic reactions.
Auvi-Q is the first-and-only epinephrine auto-injector with audio and visual cues for the emergency treatment of life-threatening allergic reactions in people who are at risk for or have a history of anaphylaxis. The size and shape of a credit card and the thickness of a smart phone, Auvi-Q is a breakthrough in epinephrine auto-injector design that talks patients and caregivers step-by-step through the injection process.
To view Multimedia News Release, go to http://www.multivu.com/mnr/59439-auvi-q-epinephrine-injection-usp-now-available-by-prescription-in-u-s
Whether looking to get slimmer and leaner or healthier and stronger, it is now more rewarding than ever with ViSalus’ PROJECT 10 Challenge. Developed to recognize and motivate people to achieve their health goals, PROJECT 10™ will award $10,000 every week in 2014 to 10 people ($1,000 each) who lose 10 lbs. or add 10 lbs. of lean muscle during their Body by Vi Challenge™.
Beginning today, people can visit challenge.com to start their PROJECT 10 Challenge by choosing a category and uploading a video. Every Monday, ViSalus will reveal the 10 weekly winners, and for each 10 lbs. lost, the company will donate 30 Vi-Shape® Nutritional Shake meals to a child in need through their PROJECT 10™ Kids program. Representing an entire month of nutritious breakfast, lunch or snack options, the donation puts an at-risk or overweight child on the path to a healthier life.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/63082-visalus-fitness-weight-loss-resolution-reward-win-1k-lose-10-lb
People who don’t have diabetes think that they are ok. But the way so many people eat, they put themselves at risk for this disease. Eating a diet high in processed foods, high sugar, and simple carbohydrates increase your chances of Type II Diabetes and especially if you are overweight. Other risk factors for Type II Diabetes are elevated triglyceride, low HDL, and high blood pressure.
Last week, Jennifer Lawrence and other celebrities had indiscrete photos stolen and distributed across the Internet. It’s speculated that their accounts were accessed by a “brute force” attack—which can only be successful if their passwords were weak.
Weak passwords are a risk for businesses, too. Verizon found that 76% of all network intrusions exploit weak or stolen passwords.
To protect critical data, every employee at every business must use strong passwords (which have no fewer than 12 characters). But with an average of 14.3 apps per business, users are likely to take shortcuts by creating passwords that are easy to memorize – and easy to crack.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7286151-intermedia-appid-single-sign-on-passwords-one-click-access/
In recognition of Men’s Health Awareness Month and the start of summer, the American Academy of Dermatology (Academy) has released findings from a new survey, which found that more than 90% of American men know something about skin cancer, but only six in 10 (61%) know how to detect signs on their skin, and even fewer actually visit a doctor for annual skin cancer screenings (18%). These shortcomings were more apparent in younger men (18-34), who were also significantly less likely to believe that they are at risk for skin cancer than men over 35 (31% vs. 42%), and are more likely to protect their skin for cosmetic reasons than they are for health reasons (32% vs. 20%).
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7074231-american-academy-of-dermatology-spot-me-skin-cancer-awareness/
Researchers have identified the first gene mutation associated with a chronic and often fatal form of neuroblastoma that typically strikes adolescents and young adults. The finding provides the first clue about the genetic basis of the long-recognized but poorly understood link between treatment outcome and age at diagnosis.
The study involved 104 infants, children and young adults with advanced neuroblastoma, a cancer of the sympathetic nervous system. Investigators discovered the ATRX gene was mutated only in patients age 5 and older. The alterations occurred most often in patients age 12 and older. These older patients were also more likely than their younger counterparts to have a chronic form of neuroblastoma and die years after their disease is diagnosed.
To view Multimedia News Release, go to http://www.multivu.com/mnr/52992-st-jude-pediatric-cancer-genome-project-neuroblastoma-research
During the third quarter, we were again able to capture the benefits of AEGON’s strategic priorities, resulting in solid earnings growth, improved profitability of sales, lower expenses and a continued strong capital position. Our franchise remains healthy, as evidenced by the particularly high level of At-Retirement and pension sales. At the same time, we are making essential investments to reshape our businesses in both our established and developing markets to respond effectively to the changing conditions and new realities. Although there are signs of gradually improving market conditions, there remains considerable uncertainty in the general economic environment. Consequently, we believe it is prudent and necessary to maintain a sufficient financial buffer while at the same time adhering to our strict risk and pricing discipline. The steps we are taking across our organization to get closer to our end customers, combined with the strength of our current position, give us full confidence in the prospects for our business going forward.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58637-aegon-quarter-3-results
International research led by University College London (UCL) as part of the ‘Cities Changing Diabetes’ partnership programme challenges current scientific understanding of the rapid rise of diabetes in cities. The findings suggest that in cities around the world, social and cultural factors play a far more important role in the spread of the epidemic than previously thought.
More than two thirds of the world’s 400 million people with diabetes live in urban areas.1,2 The year-long study for Cities Changing Diabetes, a unique public-private-academic partnership, sought to better understand what makes people vulnerable to type 2 diabetes in cities in order to inform solutions for one of the most pressing modern-day public health challenges. To explore this complex issue, more than 550 interviews were undertaken with at-risk and diagnosed people in five major cities – Copenhagen, Houston, Mexico City, Shanghai and Tianjin.
“By largely focusing on biomedical risk factors for diabetes, traditional research has not adequately accounted for the impact of social and cultural drivers of disease,” says David Napier, Professor of Medical Anthropology, UCL. “Our pioneering research will enable cities worldwide to help populations adapt to lifestyles that make them less vulnerable to diabetes.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7690951-study-rethink-rise-diabetes-in-cities/
